维普中文期刊产品整合服务
508篇 您的检索式:作者名="ALVES M A"
    题名 作者 年代 出处 被引量
1Percutaneous radiofrequency ablation for early hepatocellular carcinoma: Risk factors for survival显示文摘AIM: To evaluate outcomes of radiofrequency ablation(RFA) therapy for early hepatocellular carcinoma(HCC) and identify survival- and recurrence-related factors. METHODS: Consecutive patients diagnosed with early HCC by computed tomography(CT) or magnetic resonance imaging(MRI)(single nodule of ≤ 5 cm, or multi-(up to 3) nodules of ≤ 3 cm each) and who underwent RFA treatment with curative intent between January 2010 and August 2011 at the Instituto do Cancer do Estado de S o Paulo, Brazil were enrolled in the study. RFA of the liver tumors(with 1.0 cm ablative margin) was carried out under CT-fluoro scan and ultrasonic image guidance of the percutaneous ablation probes. Procedure-related complications were recorded. At 1-mo post-RFA and 3-mo intervals thereafter, CT and MRI were performed to assess outcomes of complete response(absence of enhancing tissue at the tumor site) or incomplete response(enhancing tissue remaining at the tumor site). Overall survival and diseasefree survival rates were estimated by the Kaplan-Meier method and compared by the log rank test or simple Cox regression. The effect of risk factors on survival was assessed by the Cox proportional hazard model. RESULTS: A total of 38 RFA sessions were performed during the study period on 34 patients(age in years: mean, 63 and range, 49-84). The mean follow-up time was 22 mo(range, 1-33). The study population showed predominance of male sex(76%), less severe liver disease(Child-Pugh A, n = 26; Child-Pugh B, n = 8), and single tumor(65%). The maximum tumor diameters ranged from 10 to 50 mm(median, 26 mm). The initial(immediately post-procedure) rate of RFAinduced complete tumor necrosis was 90%. The probability of achieving complete response was significantly greater in patients with a single nodule(vs patients with multi-nodules, P = 0.04). Two patients experienced major complications, including acute pulmonary edema(resolved with intervention) and intestinal perforation(led to death). The 1- and 2-year overall survival rates were 82% and 71%, respectively. Sex, tumor size, initial response, and recurrence status influenced survival, but did not reach the threshold of statistical significance. Child-Pugh class and the model for end-stage liver disease score were identified as predictors of survival by simple Cox regression, but only Child-Pugh class showed a statistically significant association to survival in multiple Cox regression analysis(HR = 15; 95%CI: 3-76 mo; P = 0.001). The 1-and 2-year cumulative disease-free survival rates were 65% and 36%, respectively. CONCLUSION: RFA is an effective therapy for local tumor control of early HCC, and patients with preserved liver function are the best candidates.Luciana Kikuchi Marcos Menezes Aline L Chagas Claudia M Tani Regiane SSM Alencar Marcio A Diniz Venncio AF Alves Luiz Augusto Carneiro D’Albuquerque Flair José Carrilho 2014World Journal of Gastroenterology2014,20,6:5
2Chronic myeloid leukemia-from the Philadelphia chromosome to specific target drugs:A literature review显示文摘Chronic myeloid leukemia(CML)is a myeloproliferative neoplasm and was the first neoplastic disease associated with a well-defined genotypic anomaly―the presence of the Philadelphia chromosome.The advances in cytogenetic and molecular assays are of great importance to the diagnosis,prognosis,treatment,and monitoring of CML.The discovery of the breakpoint cluster region(BCR)-Abelson murine leukemia(ABL)1 fusion oncogene has revolutionized the treatment of CML patients by allowing the development of targeted drugs that inhibit the tyrosine kinase activity of the BCR-ABL oncoprotein.Tyrosine kinase inhibitors(known as TKIs)are the standard therapy for CML and greatly increase the survival rates,despite adverse effects and the odds of residual disease after discontinuation of treatment.As therapeutic alternatives,the subsequent TKIs lead to faster and deeper molecular remissions;however,with the emergence of resistance to these drugs,immunotherapy appears as an alternative,which may have a cure potential in these patients.Against this background,this article aims at providing an overview on CML clinical management and a summary on the main targeted drugs available in that context.Mariana Miranda Sampaio Maria Luísa Cordeiro Santos Hanna Santos Marques Vinícius Lima de Souza Gonçalves Glauber Rocha Lima Araújo Luana Weber Lopes Jonathan Santos Apolonio Camilo Santana Silva Luana Kauany de SáSantos Beatriz Rocha Cuzzuol Quézia Estéfani Silva Guimarães Mariana Novaes Santos Breno Bittencourt de Brito Filipe Antônio França da Silva Márcio Vasconcelos Oliveira Cláudio Lima Souza Fabrício Freire de Melo 2021World Journal of Clinical Oncology2021,12,2:3
3Non-pharmacological management of pediatric functional abdominal pain disorders:Current evidence and future perspectives显示文摘Functional abdominal pain disorders(FAPDs) are an important and prevalent cause of functional gastrointestinal disorders among children, encompassing the diagnoses of functional dyspepsia, irritable bowel syndrome, abdominal migraine, and the one not previously present in Rome Ⅲ, functional abdominal pain not otherwise specified. In the absence of sufficiently effective and safe pharmacological treatments for this public problem, non-pharmacological therapies emerge as a viable means of treating these patients, avoiding not only possible side effects, but also unnecessary prescription, since many of the pharmacological treatments prescribed do not have good efficacy when compared to placebo. Thus, the present study provides a review of current and relevant evidence on non-pharmacological management of FAPDs, covering the most commonly indicated treatments, from cognitive behavioral therapy to meditation, acupuncture, yoga, massage, spinal manipulation, moxibustion, and physical activities. In addition, this article also analyzes the quality of publications in the area, assessing whether it is possible to state if non-pharmacological therapies are viable, safe, and sufficiently well-based for an appropriate and effective prescription of these treatments. Finally, it is possible to observe an increase not only in the number of publications on the non-pharmacological treatments for FAPDs in recent years, but also an increase in the quality of these publications. Finally, the sample selection of satisfactory age groups in these studies enables the formulation of specific guidelines for this age group, thus avoiding the need for adaptation of prescriptions initially made for adults, but for children use.Maria Luísa Cordeiro Santos Ronaldo Teixeira da Silva Júnior Breno Bittencourt de Brito Filipe Antônio França da Silva Hanna Santos Marques Vinícius Lima de SouzaGonçalves Talita Costa dos Santos Carolina Ladeia Cirne Natália Oliveira e Silva Márcio Vasconcelos Oliveira Fabrício Freire de Melo 2022World Journal of Clinical Pediatrics2022,11,2:2
4NEW TOXOPLASMA GONDII GENOTYPES ISOLATED FROM FREE-RANGE CHICKENS FROM THE FERNANDO DE NORONHA, BRAZIL: UNEXPECTED FINDINGS显示文摘Dubey J P Rajendran C Costa D G C Ferreira L R Kwok O C H Qu D Su C Marvulo M F V Alves L C Mota R A Silva J C R 2010The Journal of Parasitology2010,,4:2
5Chitosan/polyester-based scaffolds for cartilage tissue engineering: Assessment of extracellular matrix formation 显示文摘M L Alves da Silva A Crawford 2010Acta Biomaterialia2010,6,3:1
6Effects of a Saccharomyces cerevisiae yeast on ruminal fermentation and fibre degradation of maize silages in cows显示文摘Guedes C M Gon alves D Rodrigues M A M 2008Anim Feed Sci Tech2008,145,1:1
7Quantifying process equivalence based on ob- served behavior 显示文摘ALVES DE MEDEIROS A K van der AALST W M P WEIJTERS A 2008Data and Knowledge Engineering2008,64,1:1
8On the existence and con- centration behaviour of ground state solutions for a class of problems with critical growth 显示文摘Alves C O Souto M A S 2002Comm Pure Appl Anal2002,3,:1
9Spatially Confined UHF RFID DetectionWith a Metamaterial Grid显示文摘MORGADO T A ALVES J M MARCOS J S 2014Antennas and Propagation IEEE Transactions on2014,62,1:1
10DNA vaccine against the non-structural 1 protein ( NS1 ) of dengue 2 virus显示文摘Costa S M Freire M S Alves A M 2006Vaccine2006,24,:1
11On systems of elliptic equations involving subcritical or critical Sobolev exponents显示文摘Alves C O Filho D C de M Souto M A S 2000Nonlinear Analysis2000,42,:1
12Parallel strategies for the local biological sequence alignment in a cluster of workstations显示文摘Boukerche A Alves de Melo A C M Ayala-Rincon M 2007Journal of Parallel and Distributed Computing2007,67,2:1
13A geometric interpretation for transmission real losses minimization through the optimal power flow and its influence on voltage collapse显示文摘Alves D A Costa G R M 2002Electric Power Systems Research2002,62,:1
14End-to-end joining of tubes by plastic instability 显示文摘Alves L M Silva C M A Martins P A F 2014Journal of Materials Processing Technology2014,214,9:1
15Support vector machines for transient stability analysis of large-scale power systems显示文摘Moulin L S Alves da Silva A P El-Sharkawi M A 2004IEEE Transactions on Power Systems2004,19,2:1
16Quantitative study of caspase-3 activity in semen and after swim-up preparation in relation to sperm quality显示文摘Almeida C Cardoso MF Sousa M Viana P Gon(c)alves A Silva J 2005Hum Reprod2005,20,5:1
17Lean production as promoter of thinkers to achieve companies' agility 显示文摘Alves A C Dinis-Carvalho J Sousa R M 2012The Learning Organiza- tion2012,19,3:1
18Seasonal and spa- tial variability of free-living bacterial community composition a- long an estuarine gradient ( Ria de Aveiro, Portugal) 显示文摘HENRIQUES I S ALVES A TACAI M Estu- arine Coastal and Shelf Science0,,:1
19Changes in volatile com- position of Madeira wines during their oxidative ageing显示文摘Ci MARA J S ALVES M A MARQUES J C 2006Anal Chim Acta2006,563,1:1
20Right median nerve electrical stimulation to hasten awakening from coma显示文摘COOPER J B JANE J A ALVES W M 1999Brain lnj1999,13,4:1
返回顶部 每页显示:
共26页 首页 上一页 第1页 下一页 末页 /26 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费